Further, in the drug-resistant cell lines derived from small cell lung cancer (SCLC) and lung adenocarcinoma, the CNTN1 and p-AKT levels were increased upon N-cadherin and vimentin upregulation and E-cadherin downregulation. The gene discussed is CDH2; the disease is small cell lung carcinoma.